Skin Channel
Topics
Medications
Quicklinks
Related Channels
 

Calcipotriene/Betamethasone Dipropionate

Calcipotriene/betamethasone dipropionate is a drug used to treat psoriasis. It comes in two forms: a suspension (liquid) that is used on the scalp and an ointment. The medicine is generally applied once a day to the affected areas. Headache, inflammation of the hair follicles, and a burning sensation are some of the most common side effects.

What Is Calcipotriene/Betamethasone Dipropionate?

Calcipotriene/betamethasone dipropionate (Taclonex®) is a prescription medication approved for treating plaque psoriasis. It comes in the form of an ointment and a suspension (liquid). The suspension form is usually used on the scalp or body, while the ointment form is used on the body.
 
(Click What Is Calcipotriene/Betamethasone Dipropionate Used For? for more information on this topic, including possible off-label uses.)
 

Are There Side Effects?

Just like any medicine, calcipotriene/betamethasone dipropionate may cause side effects. However, not everyone who uses the drug will experience problems. In fact, most people tolerate it quite well.
 
If side effects do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious reactions are less common.
 
The most common side effects of calcipotriene/betamethasone dipropionate include:
 
 
(Click Calcipotriene/Betamethasone Dipropionate Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
 
 

Calcipotriene/Betamethasone Dipropionate Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2014 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.